Science Explorer Back to mapMap
Discussion
Company · Hoboken · United States

Octapharma (United States)

octapharmausa.com/enROR OpenAlex
Research works
40
▲ 89% vs 2018-21
Citations
428
10.7 per fractional work
Top-10% rate
11.2%
all institutions 10.0%
Open access
33%
world 40%
International
52%
world 18%
Octapharma (United States)

Not ranked overall: Octapharma (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Octapharma (United States) work in?

In all years, 67% of research at Octapharma (United States) is in Health Sciences, 19% in Life Sciences. Its largest fields are Medicine (64%), Biochemistry, Genetics and Molecular Biology (10%), Chemistry (5%). It does 2.4× the world's share of Health Sciences.

Health Sciences: 27 fractional works · 66.6% of its workMedicine: 26 fractional works · 63.9% of its workHematology: 10 fractional works · 25.0% of its workPulmonary and Respiratory Medicine: 3 fractional works · 7.7% of its workSurgery: 2 fractional works · 4.8% of its workEndocrinology, Diabetes and Metabolism: 2 fractional works · 3.7% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 2.6% of its workGenetics: 1 fractional works · 2.6% of its workBiochemistry: 1 fractional works · 2.5% of its workEpidemiology: 1 fractional works · 2.0% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 1.9% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 1.6% of its workCritical Care and Intensive Care Medicine: 1 fractional works · 1.5% of its workPsychiatry and Mental health: 0 fractional works · 1.1% of its workPhysiology: 0 fractional works · 0.9% of its workInfectious Diseases: 0 fractional works · 0.8% of its workHepatology: 0 fractional works · 0.7% of its workPharmacology: 0 fractional works · 0.7% of its workOrthopedics and Sports Medicine: 0 fractional works · 0.6% of its workPathology and Forensic Medicine: 0 fractional works · 0.5% of its workNeurology: 0 fractional works · 0.4% of its workRheumatology: 0 fractional works · 0.4% of its workUrology: 0 fractional works · 0.4% of its workEmergency Medicine: 0 fractional works · 0.4% of its workInternal Medicine: 0 fractional works · 0.3% of its workOncology: 0 fractional works · 0.2% of its workHealth Professions: 1 fractional works · 1.4% of its workGeneral Health Professions: 0 fractional works · 1.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workDentistry: 0 fractional works · 0.8% of its workPeriodontics: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNursing: 0 fractional works · 0.5% of its workNutrition and Dietetics: 0 fractional works · 0.5% of its workLife Sciences: 8 fractional works · 19.1% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 10.2% of its workMolecular Biology: 2 fractional works · 5.8% of its workGenetics: 1 fractional works · 2.7% of its workBiotechnology: 0 fractional works · 0.4% of its workCancer Research: 0 fractional works · 0.4% of its workCell Biology: 0 fractional works · 0.4% of its workBiochemistry: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 2 fractional works · 3.7% of its workPlant Science: 2 fractional works · 3.7% of its workImmunology and Microbiology: 1 fractional works · 2.7% of its workImmunology: 1 fractional works · 2.3% of its workVirology: 0 fractional works · 0.4% of its workNeuroscience: 1 fractional works · 2.1% of its workCellular and Molecular Neuroscience: 1 fractional works · 1.6% of its workBiological Psychiatry: 0 fractional works · 0.4% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.3% of its workPhysical Sciences: 4 fractional works · 9.1% of its workChemistry: 2 fractional works · 5.1% of its workOrganic Chemistry: 1 fractional works · 2.9% of its workSpectroscopy: 0 fractional works · 1.2% of its workAnalytical Chemistry: 0 fractional works · 1.0% of its workMaterials Science: 1 fractional works · 3.1% of its workBiomaterials: 1 fractional works · 1.7% of its workPolymers and Plastics: 0 fractional works · 1.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysics and Astronomy: 0 fractional works · 0.8% of its workAtomic and Molecular Physics, and Optics: 0 fractional works · 0.8% of its workEngineering: 0 fractional works · 0.1% of its workSocial Sciences: 2 fractional works · 5.3% of its workBusiness, Management and Accounting: 1 fractional works · 3.3% of its workManagement of Technology and Innovation: 1 fractional works · 2.1% of its workManagement Information Systems: 0 fractional works · 1.2% of its workEconomics, Econometrics and Finance: 0 fractional works · 1.2% of its workEconomics and Econometrics: 0 fractional works · 1.2% of its workPsychology: 0 fractional works · 0.7% of its workClinical Psychology: 0 fractional works · 0.7% of its workALL ITS WORKOctapharma(United States)40fractional works, all years
Life Sciences19%Physical Sciences9%Health Sciences67%Social Sciences5%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 16 fields, with their numbers
    1. Medicine2663.9%
    2. Health Professions11.4%
    3. Dentistry00.8%
    4. Nursing00.5%
    1. Biochemistry, Genetics and Molecular Biology410.2%
    2. Agricultural and Biological Sciences23.7%
    3. Immunology and Microbiology12.7%
    4. Neuroscience12.1%
    5. Pharmacology, Toxicology and Pharmaceutics00.3%
    1. Chemistry25.1%
    2. Materials Science13.1%
    3. Physics and Astronomy00.8%
    4. Engineering00.1%
    1. Business, Management and Accounting13.3%
    2. Economics, Econometrics and Finance01.2%
    3. Psychology00.7%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.53× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 5.62× its world share, 0 worksImmunology and Micro…Neuroscience: 1.83× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 4.05× its world share, 0 worksPharmacology, Toxico…Chemistry: 3.64× its world share, 0 worksChemistryMaterials Science: 0.75× its world share, 0 worksMaterials ScienceHealth Professions: 0.10× its world share, 0 worksHealth ProfessionsMedicine: 3.29× its world share, 6 worksMedicineNursing: 1.94× its world share, 0 worksNursingBusiness, Management and Accounting: 2.40× its world share, 1 worksBusiness, Management…Psychology: 0.39× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 5.6×. Every wedge is a field page.

All 11 fields, with their numbers
  1. Immunology and Microbiology5.62×0 works
  2. Pharmacology, Toxicology and Pharmaceutics4.05×0 works
  3. Chemistry3.64×0 works
  4. Medicine3.29×6 works
  5. Business, Management and Accounting2.40×1 works
  6. Nursing1.94×0 works
  7. Neuroscience1.83×0 works
  8. Biochemistry, Genetics and Molecular Biology1.53×1 works
  9. Materials Science0.75×0 works
  10. Psychology0.39×0 works
  11. Health Professions0.10×0 works

Who are the top researchers at Octapharma (United States)?

Ranked on the quality score, John P. Feighner, Bruce A. Schwartz and Gabriela Nicolau lead among researchers whose main affiliation is Octapharma (United States).

  1. 1 John P. Feighner United States · #438,297 worldwide 12k citations · 111 works
  2. 2 Bruce A. Schwartz United States · #1,756,465 worldwide 2.2k citations · 69 works
  3. 3 Gabriela Nicolau United States · #2,225,538 worldwide 1k citations · 56 works
  4. 4 Sylvia Werner United States · #2,288,488 worldwide 127 citations · 18 works
  5. 5 G. Tonelli United States · #2,650,160 worldwide 297 citations · 21 works
  6. 6 Birte Fuchs United States · #4,078,729 worldwide 270 citations · 18 works
  7. 7 B. Schwartz United States · #4,157,653 worldwide 170 citations · 15 works
  8. 8 Lev Sverdlov United States · #4,780,540 worldwide 333 citations · 23 works
All ranked researchers at Octapharma (United States)

What are the most cited papers from Octapharma (United States)?

The most cited paper from Octapharma (United States) is "Interference of Maltose, Icodextrin, Galactose, or Xylose with Some Blood Glucose Monitoring Systems" (Thomas G. Schleis, 2007), with 102 citations. Next come "The first recombinant human coagulation factor VIII of human origin: human cell line and manufacturing characteristics" (89) and "Prothrombin Complex Concentrate vs Frozen Plasma for Coagulopathic Bleeding in Cardiac Surgery" (58).

Most cited papers
#PaperReleasedCitations
1 Interference of Maltose, Icodextrin, Galactose, or Xylose with Some Blood Glucose Monitoring Systems Thomas G. Schleis · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy 27 Aug 2007 102
2 The first recombinant human coagulation factor VIII of human origin: human cell line and manufacturing characteristics Elisabeth Casademunt, Kristina Martinelle, Mats Jernberg et al. · European Journal Of Haematology Open access 13 Jun 2012 89
3 Prothrombin Complex Concentrate vs Frozen Plasma for Coagulopathic Bleeding in Cardiac Surgery Keyvan Karkouti et al. · JAMA Open access149 authors 29 Mar 2025 58
4 Minocycline HCl Microspheres Reduce Red‐Complex Bacteria in Periodontal Disease Therapy J. Max Goodson, John C. Gunsolley, Sara G. Grossi et al. · Journal of Periodontology Aug 2007 56
5 Systemic therapy for unresectable, mixed hepatocellular-cholangiocarcinoma: treatment of a rare malignancy Jane Elizabeth Rogers, Ryan M. Bolonesi, Asif Rashid et al. · Journal of Gastrointestinal Oncology Open access Apr 2017 50
All 80 most cited papers, with filters and sorting

Which keywords describe research at Octapharma (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Hemostasis, Prophylaxis, Gene Therapy, Factor VIII, Hemophilia, Thrombosis, Inflammation and Immune Thrombocytopenic Purpura.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 38 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 38 words, with their numbers
  1. Hemostasis7▲ 116×4 topics
  2. Inflammation4▲ 4.5×7 topics
  3. Prophylaxis4▲ 76×3 topics
  4. Gene Therapy4▲ 39×2 topics
  5. Factor VIII4▲ 573×1 topic
  6. Hemophilia4▲ 573×1 topic
  7. Thrombosis4▲ 42×2 topics
  8. Immune Thrombocytopenic Purpura3▲ 211×1 topic
  9. Platelets3▲ 130×1 topic
  10. Fibrinogen3▲ 245×1 topic
  11. Transglutaminases3▲ 245×1 topic
  12. Anemia3▲ 62×2 topics
  13. Alloimmunization2▲ 123×1 topic
  14. Blood Groups2▲ 123×1 topic
  15. Blood Transfusion2▲ 85×2 topics
  16. Depression2▲ 5.8×5 topics
  17. Epidemiology2◆ 1.01×12 topics
  18. Hemorrhage2▲ 55×2 topics
  19. Critical Care2▲ 17×2 topics
  20. Monoclonal Antibodies2▲ 27×3 topics
  21. Therapeutic Antibodies1▲ 28×2 topics
  22. Diagnosis1▲ 3.1×6 topics
  23. Stability1▲ 17×2 topics
  24. Risk Factors1▲ 2.8×4 topics
  25. Antioxidant1▲ 4.2×3 topics
  26. Apoptosis Induction1▲ 51×2 topics
  27. Genetic Mutations1▲ 5.2×2 topics
  28. Genetics1▲ 3.6×5 topics
  29. Treatment1▲ 2.1×9 topics
  30. Carbene Chemistry1▲ 95×1 topic
  31. Cardiac Surgery1▲ 32×1 topic
  32. Cyclopropanation1▲ 95×1 topic
  33. Garcinia Mangostana1▲ 350×1 topic
  34. Glycemic Control1▲ 18×2 topics
  35. Insulin Therapy1▲ 23×2 topics
  36. Protein Aggregation1▲ 32×2 topics
  37. St John's Wort1▲ 350×1 topic
  38. Tranexamic Acid1▲ 120×1 topic

Which research topics does Octapharma (United States) publish most on?

By volume in 2022-now: Hemophilia Treatment and Research, Platelet Disorders and Treatments, FinTech, Crowdfunding, Digital Finance and Immunodeficiency and Autoimmune Disorders.

Hemophilia Treatment and…1Hemophilia Treatment and Research: 1 fractional worksPlatelet Disorders and T…1Platelet Disorders and Treatments: 1 fractional worksFinTech, Crowdfunding, D…0FinTech, Crowdfunding, Digital Finance: 0 fractional worksImmunodeficiency and Autoimmune Disorders: 0 fractional worksMyeloproliferative Neoplasms: Diagnosis and Treatment: 0 fractional worksAtrial Fibrillation Management and Outcomes: 0 fractional worksBlood transfusion and management: 0 fractional worksBlood properties and coagulation: 0 fractional worksBlood Coagulation and Thrombosis Mechanisms: 0 fractional worksTrauma, Hemostasis, Coagulopathy, Resuscitation: 0 fractional works
HematologyManagement Information SystemsImmunologyGenetics4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Hemophilia Treatment and Research Hematology 1 works
  2. 2 Platelet Disorders and Treatments Hematology 1 works
  3. 3 FinTech, Crowdfunding, Digital Finance Management Information Systems 0 works
  4. 4 Immunodeficiency and Autoimmune Disorders Immunology 0 works
  5. 5 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 0 works
  6. 6 Atrial Fibrillation Management and Outcomes Cardiology and Cardiovascular Medicine 0 works
  7. 7 Blood transfusion and management Biochemistry 0 works
  8. 8 Blood properties and coagulation Pulmonary and Respiratory Medicine 0 works
  9. 9 Blood Coagulation and Thrombosis Mechanisms Hematology 0 works
  10. 10 Trauma, Hemostasis, Coagulopathy, Resuscitation Critical Care and Intensive Care Medicine 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available32.9%not open67.1%

World: 40% of research is openly available.

with international co-authors51.6%domestic only48.4%

World: 18% is written across borders.

How has Octapharma (United States)'s research output changed?

Output in 2022-2025 was 89% higher than in 2018-2021.

still counting200020052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Octapharma (United States) as a percentage of every work published that year, 0.000020% in 2024.

still counting0.00010%0.00020%Octapharma (United States)0.000045% in 2025200020102020

Fractional works of Octapharma (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Hoboken

All research institutions in Hoboken

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Octapharma (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.